The gout medication colchicine will be tested in a large UK study looking into potential early-stage Covid-19 treatments and enrollment criteria was widened for the latest arm of the trial, University of Oxford researchers said on March 3.
The AMR Action Fund – which was unveiled during 2020 by more than 20 drugmakers to help struggling antibiotic companies – received $140 million from a group of new investors, including the European Investment Bank.
Sandoz, a division of Swiss-based Novartis, inked a deal to buy U.K.-based GlaxoSmithKline’s cephalosporin antibiotics business.
Chemo Drug Potentially More Potent than Remdesivir Against Coronavirus
Antibiotics, Chemotherapeutics, Chemotherapy, China, Clinical Studies, Clinical Trials, Coronavirus Disease 2019 (COVID-19), Drug screenings, Peripheral T-Cell Lymphoma (PTCL), PLOS Computational Biology, R&D, Remdesivir, Researchers, RNA, SARS-CoV-2 virus, TherapeuticsThe chemotherapy pralatrexate and the antibiotic azithromycin were successful at preventing replication of the SARS-CoV-2 virus, according to research with Shenzhen Institutes of Advanced Technology in China.
Single-patient study adds to debate over Gilead’s remdesivir for Covid-19
Antivirals, Azithromycin, Clinical Trials, Coronavirus Disease (COVID-19) Pandemic, COVID-19 Studies, Doctors, Hydroxychloroquine, Medical Journals, Nature Communications, R&D, Remdesivir, Scientists, Survival Rates, World Health OrganizationA single-patient study conducted by British scientists found that Gilead’s remdesivir could be highly effective against Covid-19, raising questions about previous studies that found the antiviral drug had no impact on death rates from the disease.
A clinical trial of the widely used antibiotic azithromycin in hospitalized Covid-19 patients found no convincing evidence of benefit, prompting doctors to announce that they have closed that section of the trial.
The European Commission wants to make it easier for patients to access cheaper generic medicines, a draft EU document seen by Reuters shows, in a move that could cut the revenues of big pharmaceutical firms.
Covid-19 heart changes raise death risk; virus may be lead killer of young adults during surges
American College of Cardiology, Antibiotic overuse, Coronavirus, Coronavirus Disease (COVID-19) Pandemic, COVID-19 Deaths, Data, Department of Health and Human Services (HHS), Doctors, Heart Injury, Hospitalized COVID-19 Patients, Outbreaks, R&D, U.S. Centers for Disease Control and Prevention, United States, Young AdultsIn a roundup of some of the latest scientific studies on the novel coronavirus and efforts to find treatments and vaccines for Covid-19, a new study may help identify which Covid-19 patients with signs of heart injury are at higher risk for death.
Severe Covid-19 riskier than heart attack for young adults; antibiotic shows no benefit
African-Americans, Antibiotics, Antimalarial, Azithromycin, Clinical Studies, Coronavirus Disease 2019 (COVID-19), Heart Attacks, Hispanics, Hospitalized COVID-19 Patients, Hydroxychloroquine, Lung Damage, Middle-Aged Adults, R&D, Surveys, Young AdultsA roundup of some of the latest scientific studies on the novel coronavirus and efforts to find treatments and vaccines for Covid-19, the illness caused by the virus.
The U.S. Food and Drug Administration approved Italy-based Cassiopea SpA’s acne treatment Winlevi (clascoterone cream 1%).